<code id='155C080CD9'></code><style id='155C080CD9'></style>
    • <acronym id='155C080CD9'></acronym>
      <center id='155C080CD9'><center id='155C080CD9'><tfoot id='155C080CD9'></tfoot></center><abbr id='155C080CD9'><dir id='155C080CD9'><tfoot id='155C080CD9'></tfoot><noframes id='155C080CD9'>

    • <optgroup id='155C080CD9'><strike id='155C080CD9'><sup id='155C080CD9'></sup></strike><code id='155C080CD9'></code></optgroup>
        1. <b id='155C080CD9'><label id='155C080CD9'><select id='155C080CD9'><dt id='155C080CD9'><span id='155C080CD9'></span></dt></select></label></b><u id='155C080CD9'></u>
          <i id='155C080CD9'><strike id='155C080CD9'><tt id='155C080CD9'><pre id='155C080CD9'></pre></tt></strike></i>

          Home / comprehensive / leisure time

          leisure time


          leisure time

          author:Wikipedia    Page View:41744
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In